ALPHA registry is evaluating safety and effectiveness of the LOBO vascular occlusion system in peripheral vascular conditions, including arterial hemorrhage and pulmonary arteriovenous malformation.

Exxon Mobil (XOM) was reiterated Tuesday at UBS with a Buy rating and $171 price target,which cited mounting concerns over global helium supply disruptions caused by Iran's drone and missile strikes ...

The Trump administration will increase average Medicare Advantage payments by 2.48%, or more than $13 billion, in 2027, according to Centers for Medicare & Medicaid Services (CMS). The Trump ...

Increasingly, tax-efficient investing is playing a larger role in today’s investment landscape, but what is it, and how is it being applied in practice? We spoke with three experienced professionals ...